Market Cap
₹ 7,028 Cr
P/E
50.63
Bearish
4
Neutral
7
Bullish
3
Bearish
12
Neutral
31
Bullish
3
Bearish
8
Neutral
24
Bullish
0
Investor Presentation
Q2 FY26
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
7,028 Cr
Low Risk
50.6
31.1
2.3
12.0
795.80
621.00
Sales CAGR
1Y
9.30%
3Y
1.13%
5Y
—
10Y
—
Profit CAGR
1Y
4.14%
3Y
22.33%
5Y
—
10Y
—
ROE
TTM
31.20%
3Y
26.06%
5Y
27.09%
10Y
—
ROCE
TTM
36.21%
3Y
33.97%
5Y
34.49%
10Y
—
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Performance
UNDER PERFORMER
Valuation
OVERVALUED
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Neutral
Risk
MODERATE RISK
Earnings Call
1 day ago
Earnings Call Transcript Submission
This announcement pertains to the submission of the transcript from Sudeep Pharma's earnings conference call discussing their Q2 FY26 financial results.
Analyst/Investor Meet
4 days ago
Investor Call Audio Recording Submission
The company has submitted the audio link for the earnings call held on December 22, 2025, in compliance with SEBI regulations.
Investor Presentation
5 days ago
Investor Presentation Submission by Sudeep Pharma
Sudeep Pharma Limited submits its Q2FY26 Investor Presentation ahead of its earnings call scheduled for December 22, 2025, detailing operational and financial performance.